Cellulite startup Eleme Medical on Thursday said it sucked up $18 million.
The Merrimack, New Hampshire, company picked up new investor Hambrecht & Quist Capital Management and included previous investor L Capital Partners in the round.
"We are intrigued by the immense size of the potential market for the SmoothShapes device," Ting Pau Oei of L Capital Partners said in a statement.
Eleme plans to use the funding toward commercialization of its FDA-approved SmoothShapes cellulite treatment and for development of others.
Eleme's technology promises to be a boon for Silicon Valley's overweight entrepreneurs and startup employees, among others.